Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 27 Mar 2024: AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan AstraZeneca Pharma India gains CDSCO approval for Trastuzumab deruxtecan lyophilised powder for solution for infusion 100mg, expanding treatment […]
Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 26 Mar 2024: NextCure and LegoChem Biosciences partner to develop Antibody Drug Conjugates NextCure Inc and LegoChem Biosciences Inc collaborate on developing a B7-H4 antibody-drug conjugate and explore options for […]
Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 25 Mar 2024: Bio-Thera Solutions receives FDA clearance for Phase II Study of BAT8006, a Novel ADC Targeting Folate Receptor α Bio-Thera Solutions receives FDA IND clearance for phase II […]
Weekly Digest – Mar 2024 Weekly Digest – Mar 2024 25 Mar 2024: Biocytogen Pharmaceuticals (Beijing) and ABL Bio Inc. announce a collaboration to develop innovative bispecific antibody-drug conjugates (bsADCs) Biocytogen’s RenLite mice platform facilitates the efficient production of fully […]
